Efficacy of Sovateltide (PMZ-1620) in Patients of Acute Ischemic Stroke

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 158 participants.

Also called NCT04047563

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 158 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT04047563
Other papers using this trial's data
  • Efficacy and Safety of Sovateltide in Patients with Acute Cerebral Ischaemic Stroke: A Randomised, Double-Blind, Placebo-Controlled, Multicentre, Phase III Clinical Trial Drugs, 2024-12 DOI, PubMed 39542995, PMC11652401 In the PMC Open Access subset under CC BY-NC.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
India (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT04047563. Randomized; quadruple masking; primary purpose treatment. Start 2019-11-10 (actual); primary completion 2022-02-10 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Efficacy of Sovateltide (PMZ-1620) in Patients of Acute Ischemic Stroke
Condition
Cerebral Ischemia
Condition
Cerebral Infarction
Condition
Stroke, Acute
Intervention (Drug)
Normal Saline along with standard treatment
Intervention (Drug)
PMZ-1620 (sovateltide) along with standard treatment
Lead sponsor
Pharmazz, Inc. (class: industry)

Record details

Record id
cardio:ct-nct04047563
Content hash
fcc471c3ff286512b88359538e9ccf27506e6bb2568599258c54446fd7a3636b